Interventional Radiology Imaging

When to Order Imaging for Central Venous Access Device and Site Selection: ACR Appropriateness Decoded

Selecting the right central venous access device (CVAD) and insertion site is a critical decision point for inpatients and outpatients alike, impacting everything from patient comfort to long-term vessel preservation. For the hospitalist, emergency physician, or consulting specialist, the choice between a peripherally inserted central catheter (PICC), a tunneled line, or a port depends on the patient’s diagnosis, the type and duration of therapy, and underlying comorbidities like chronic kidney disease. Missteps can lead to premature device failure, infection, or thrombosis. This guide synthesizes the American College of Radiology (ACR) Appropriateness Criteria to clarify which device and site are best suited for common clinical scenarios, providing evidence-based support for your next access consult or order.

What Does ACR Central Venous Access Device and Site Selection Cover?

These ACR guidelines, developed by an expert panel of interventional radiologists, focus on two primary clinical questions: which type of central venous access device is most appropriate, and which venous site is the optimal choice for cannulation? The criteria address a range of common indications, including short-term and long-term infusion of medications, chemotherapy, renal replacement therapy, and total parenteral nutrition (TPN). The recommendations are stratified by the anticipated duration of therapy and key patient factors, most notably the presence of chronic kidney disease (CKD), which significantly influences device and site selection to preserve future hemodialysis access options. These guidelines are intended for both adult and pediatric populations. They do not cover the management of complications of existing central lines (such as catheter-related thrombosis or infection), techniques for difficult access, or criteria for peripheral intravenous (IV) or midline catheters, which do not terminate in a central vein.

What Imaging Should I Order for Central Venous Access Device and Site Selection? Recommendations by Clinical Scenario

The appropriate central venous access device is determined by the intended use, duration, and patient-specific factors. The ACR provides clear guidance for these common clinical situations.

For an acutely ill patient requiring infusion of an irritant medication, hemodynamic monitoring, and frequent blood draws for 2 weeks or shorter, both a Nontunneled central venous catheter and a PICC are rated Usually appropriate. These devices provide reliable, multi-lumen access for the short-term needs of critically ill patients. A tunneled catheter may be appropriate in some cases, but implanted ports are considered Usually not appropriate for this brief timeframe. For patients needing long-term TPN, a Tunneled central venous catheter double lumen or a Double lumen PICC is Usually appropriate to accommodate high-flow, viscous infusions while maintaining a separate lumen for other medications or blood draws. IR Central Venous Access (PICC, Tunneled, Port) provides detailed procedural protocols.

In patients with renal failure, access decisions are critical for preserving future dialysis circuits. For acute renal failure requiring renal replacement therapy for 2 weeks or shorter, a Nontunneled dialysis catheter or a Tunneled dialysis catheter is Usually appropriate. If the anticipated duration is more than 2 weeks, the recommendation shifts, with a Tunneled dialysis catheter becoming Usually appropriate and a nontunneled catheter downgraded to May be appropriate. For all renal failure scenarios, PICCs and ports are Usually not appropriate to avoid damaging upper extremity veins vital for future fistula creation.

For oncology patients, device choice balances frequent access needs with patient lifestyle. In a patient with a cancer diagnosis requiring weekly chemotherapy for more than 2 weeks, both a Chest port and an Arm port are Usually appropriate. These fully implanted devices minimize infection risk and interference with daily activities. A PICC or tunneled catheter May be appropriate depending on specific circumstances. Pre-procedure staging or restaging often involves cross-sectional imaging, detailed in our guide to CT Chest/Abdomen/Pelvis with IV Contrast.

For patients with chronic kidney disease requiring central venous catheter IV infusions for more than 2 weeks (for non-dialysis indications), vessel preservation remains paramount. A Tunneled central venous catheter (single or double lumen) is Usually appropriate. A chest port placed via the internal jugular vein May be appropriate, but a subclavian approach is Usually not appropriate due to the high risk of central venous stenosis. Critically, both PICCs and arm ports are rated Usually not appropriate to protect the peripheral veins of the arms.

When selecting an access site, for an acutely ill patient with an anticipated therapy duration of 2 weeks or shorter, the Internal jugular vein, Subclavian vein, and Upper extremity veins are all Usually appropriate. The femoral vein May be appropriate but is often avoided due to a perceived higher infection risk. For patients with chronic kidney disease or end-stage renal disease, the Internal jugular vein is Usually appropriate, while upper extremity veins are Usually not appropriate. The subclavian vein May be appropriate but is often a last resort due to the risk of stenosis that could compromise a future arteriovenous fistula. Procedural details for site evaluation can be found in related guides like MRI Internal Auditory Canals.

ACR Imaging Recommendations Table

Clinical Scenario Top Procedure ACR Rating Adult RRL Pediatric RRL
Device selection: Acutely ill patient requiring infusion of an irritant medication, hemodynamic monitoring, and frequent blood draws for 2 weeks or shorter. Nontunneled central venous catheter; PICC Usually appropriate
Device selection: Patient with acute renal failure requiring central venous access for renal replacement therapy, anticipated duration of therapy for 2 weeks or shorter. Nontunneled dialysis catheter; Tunneled dialysis catheter Usually appropriate
Device selection: Patient with renal failure requiring central venous access for renal replacement therapy, anticipated duration of therapy for more than 2 weeks. Tunneled dialysis catheter Usually appropriate
Device selection: Patient with cancer diagnosis requiring central venous access for weekly chemotherapy infusion for more than 2 weeks. Chest port; Arm port Usually appropriate
Device selection: Patient requiring continuous or very frequent intravenous administration of intravenous medications (excluding total parenteral nutrition) for more than 2 weeks. PICC; Tunneled central venous catheter Usually appropriate
Device selection: Patient requiring long-term total parenteral nutrition and another indication for central access. Tunneled central venous catheter double lumen; Double lumen PICC Usually appropriate
Device selection: Patient with chronic kidney disease requiring central venous catheter IV infusions for more than 2 weeks. Tunneled central venous catheter single lumen; Tunneled central venous catheter double lumen Usually appropriate
Site selection: Patient with acute illness requiring central venous catheter for anticipated therapy for 2 weeks or shorter. Right or left internal jugular vein; Right or left subclavian vein; Upper extremity vein Usually appropriate
Site selection: Patient with chronic kidney disease or end-stage renal disease requiring central venous catheter. Right or left internal jugular vein Usually appropriate

Adult vs. Pediatric Central Venous Access Device and Site Selection Imaging: Radiation Dose Tradeoffs

The ACR criteria for central venous access device and site selection do not specify different appropriateness ratings for adult versus pediatric patients in the reviewed variants. The procedures involved, primarily ultrasound guidance with fluoroscopic confirmation, do involve ionizing radiation. While the provided scenarios do not have specific Relative Radiation Levels (RRLs), the As Low As Reasonably Achievable (ALARA) principle is a cornerstone of pediatric imaging and procedures. For any procedure involving fluoroscopy, efforts should be made to minimize radiation dose by using pulsed fluoroscopy, minimizing beam-on time, collimating tightly to the area of interest, and using the lowest acceptable frame rate. In pediatric patients, long-term considerations are magnified. Site selection must prioritize the preservation of venous pathways for potential future needs. Device selection may also be influenced by the child’s activity level, the ability of caregivers to maintain the device, and the smaller caliber of the patient’s vessels.

Imaging Protocol Details for Central Venous Access Device and Site Selection

Once you’ve decided on the right study, the protocol matters. Our protocol guides cover technique, contrast, and reading principles for the studies recommended above. These resources are designed to help clinicians and trainees understand the key details behind each procedure.

Tools to Help You Order the Right Study

Navigating imaging guidelines can be complex. GigHz offers a suite of tools designed to streamline clinical decision-making and ensure you are ordering the most appropriate, evidence-based imaging for your patients.

For scenarios not covered here, the Imaging Appropriateness Selector provides a comprehensive, searchable interface for the full ACR guidelines, covering thousands of clinical variants across all modalities. This tool helps you quickly find evidence-based recommendations for a wide range of clinical questions.

Once an imaging study is chosen, our Imaging Protocol Library offers detailed, institution-level protocols. These guides provide specific parameters for acquisition, contrast administration, and post-processing, helping to standardize care and optimize diagnostic quality.

To help manage and communicate radiation exposure with patients, the Radiation Dose Calculator allows for the estimation of effective dose from various imaging studies. This is particularly useful for tracking cumulative exposure in patients requiring frequent imaging and for facilitating informed discussions about the risks and benefits of a procedure.

What is the main difference between a PICC and a tunneled catheter?

A PICC is inserted into a peripheral vein in the arm (like the basilic, brachial, or cephalic vein) and advanced until the tip terminates in a large central vein, typically the superior vena cava. It is secured at the skin with an adhesive dressing. A tunneled catheter is inserted directly into a central vein (like the internal jugular) and then “tunneled” under the skin for a short distance to a separate exit site on the chest wall. This tunnel has a Dacron cuff that promotes tissue ingrowth, which helps secure the catheter and acts as a barrier to infection, making it more suitable for long-term use.

Why are PICCs “usually not appropriate” for patients with chronic kidney disease?

Patients with chronic kidney disease (CKD), especially those who may eventually require hemodialysis, need to preserve the veins in their arms for the future creation of an arteriovenous (AV) fistula or graft. Placing a PICC can cause thrombosis, inflammation, or stenosis in these peripheral and central veins, potentially rendering that arm unsuitable for a future permanent dialysis access. Therefore, guidelines strongly recommend avoiding PICCs in CKD patients to protect these vital “lifeline” vessels.

When is a femoral vein approach appropriate for central access?

According to the ACR, a femoral vein approach “may be appropriate” for both acute and chronic central access needs. It is typically not a first-line choice, especially in ambulatory patients, due to concerns about higher infection rates and patient discomfort. However, it becomes a necessary option when access to chest and neck veins is compromised (e.g., due to thrombosis, prior surgery, or radiation) or in emergency situations where other sites are not readily accessible.

What makes an arm port or chest port “usually not appropriate” for short-term (less than 2 weeks) access?

Ports are fully implanted devices that require a minor surgical procedure for placement and another for removal. This involves creating a subcutaneous pocket and tunneling the catheter. The procedure is more invasive and costly than placing a temporary line like a nontunneled catheter or a PICC. For therapy expected to last only two weeks or less, the risks, cost, and procedural burden of placing and then removing a port are not justified when simpler, less invasive options are available.

Why is the subclavian vein sometimes avoided for access in CKD patients?

The subclavian vein is known to have a higher incidence of central venous stenosis compared to the internal jugular vein after catheterization. This “pinching” effect between the clavicle and the first rib can lead to scarring and narrowing of the vein. For a patient with CKD, subclavian vein stenosis can cause severe arm swelling and dysfunction of a future AV fistula or graft placed in that arm, effectively compromising that entire extremity for dialysis access. For this reason, the internal jugular vein is the preferred site for tunneled catheters in the CKD population.

Frequently Asked Questions

What is the main difference between a PICC and a tunneled catheter?

A PICC is inserted into a peripheral vein in the arm (like the basilic, brachial, or cephalic vein) and advanced until the tip terminates in a large central vein, typically the superior vena cava. It is secured at the skin with an adhesive dressing. A tunneled catheter is inserted directly into a central vein (like the internal jugular) and then “tunneled” under the skin for a short distance to a separate exit site on the chest wall. This tunnel has a Dacron cuff that promotes tissue ingrowth, which helps secure the catheter and acts as a barrier to infection, making it more suitable for long-term use.

Why are PICCs “usually not appropriate” for patients with chronic kidney disease?

Patients with chronic kidney disease (CKD), especially those who may eventually require hemodialysis, need to preserve the veins in their arms for the future creation of an arteriovenous (AV) fistula or graft. Placing a PICC can cause thrombosis, inflammation, or stenosis in these peripheral and central veins, potentially rendering that arm unsuitable for a future permanent dialysis access. Therefore, guidelines strongly recommend avoiding PICCs in CKD patients to protect these vital “lifeline” vessels.

When is a femoral vein approach appropriate for central access?

According to the ACR, a femoral vein approach “may be appropriate” for both acute and chronic central access needs. It is typically not a first-line choice, especially in ambulatory patients, due to concerns about higher infection rates and patient discomfort. However, it becomes a necessary option when access to chest and neck veins is compromised (e.g., due to thrombosis, prior surgery, or radiation) or in emergency situations where other sites are not readily accessible.

What makes an arm port or chest port “usually not appropriate” for short-term (less than 2 weeks) access?

Ports are fully implanted devices that require a minor surgical procedure for placement and another for removal. This involves creating a subcutaneous pocket and tunneling the catheter. The procedure is more invasive and costly than placing a temporary line like a nontunneled catheter or a PICC. For therapy expected to last only two weeks or less, the risks, cost, and procedural burden of placing and then removing a port are not justified when simpler, less invasive options are available.

Why is the subclavian vein sometimes avoided for access in CKD patients?

The subclavian vein is known to have a higher incidence of central venous stenosis compared to the internal jugular vein after catheterization. This “pinching” effect between the clavicle and the first rib can lead to scarring and narrowing of the vein. For a patient with CKD, subclavian vein stenosis can cause severe arm swelling and dysfunction of a future AV fistula or graft placed in that arm, effectively compromising that entire extremity for dialysis access. For this reason, the internal jugular vein is the preferred site for tunneled catheters in the CKD population.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 26, 2026